International Journal of Molecular Sciences · 2022 · 31 citations · 40 references
Life SciencesCell BiologyPharmacologyCellular MetabolismCellular PharmacologyMitochondrial BiologyMitochondrial BiochemistryMitochondrial DysfunctionMitochondrial PhysiologyMitochondrial ToxicityMitochondrial ToxicologyOxidative Damage To BiomoleculesCardiac Mitochondrial FunctionMitochondrial Function In CardiomyocytesMitochondrial Membrane ToxicityMitochondrial Oxidative StressMitochondrial Respiratory Chain InhibitionMitochondrial Respiratory Chain ToxicityMitochondrial Toxicity MechanismsRespiratory Enzyme Complexes
Tyrosine kinase inhibitors (TKIs) are associated with cardiac toxicity, which may be caused by mitochondrial toxicity. The underlying mechanisms are currently unclear and require further investigation. In the present study, we aimed to investigate in more detail the role of the enzyme complexes of the electron transfer system (ETS), mitochondrial oxidative stress, and mechanisms of cell death in cardiac toxicity associated with imatinib and sorafenib. Cardiac myoblast H9c2 cells were exposed to imatinib and sorafenib (1 to 100 µM) for 24 h. Permeabilized rat cardiac fibers were treated with both drugs for 15 min. H9c2 cells exposed to sorafenib for 24 h showed a higher membrane toxicity and ATP depletion in the presence of galactose (favoring mitochondrial metabolism) compared to glucose (favoring glycolysis) but not when exposed to imatinib. Both TKIs resulted in a higher dissipation of the mitochondrial membrane potential in galactose compared to glucose media. Imatinib inhibited Complex I (CI)- and CIII- linked respiration under both conditions. Sorafenib impaired CI-, CII-, and CIII-linked respiration in H9c2 cells cultured with glucose, whereas it inhibited all ETS complexes with galactose. In permeabilized rat cardiac myofibers, acute exposure to imatinib and sorafenib decreased CI- and CIV-linked respiration in the presence of the drugs. Electron microscopy showed enlarged mitochondria with disorganized cristae. In addition, both TKIs caused mitochondrial superoxide accumulation and decreased the cellular GSH pool. Both TKIs induced caspase 3/7 activation, suggesting apoptosis as a mechanism of cell death. Imatinib and sorafenib impaired the function of cardiac mitochondria in isolated rat cardiac fibers and in H9c2 cells at plasma concentrations reached in humans. Both imatinib and sorafenib impaired the function of enzyme complexes of the ETS, which was associated with mitochondrial ROS accumulation and cell death by apoptosis.
40
A History of Cancer Chemotherapy
Vincent T. DeVita, Edward Chu · Cancer Research · 2008 · 1.9K citations · Full text
Medicine, Oncology, Pharmacology +12
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Risto Kerkelä, Luanda Grazette, Rinat Yacobi et al. · Nature Medicine · 2006 · 1.2K citations
Medicine, Oncology, Pharmacology +10
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F. Chu, Maria A. Rupnick, Risto Kerkelä et al. · The Lancet · 2007 · 1.1K citations · Full text